{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:47:08Z","timestamp":1747223228731,"version":"3.40.5"},"reference-count":23,"publisher":"Pensoft Publishers","issue":"2","license":[{"start":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:00:00Z","timestamp":1651276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p>Myotonic dystrophy type 1 or Steinert\u2019s disease is an autosomal dominant multisystem disease which is characterized by consistent contracture of muscle following stimulation (myotonia). Hypothermia, shivering, mechanical or electric stimulation during surgery can precipitate episodes of myotonia which may complicate the course of anaesthesia. The present case report focuses on successful strategies for providing general anaesthesia for laparoscopic cholecystectomy in a patient affected by this genetic disorder, at a hospital which does not have the facility for postoperative ventilation.<\/jats:p>","DOI":"10.3897\/folmed.64.e59905","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:56:20Z","timestamp":1652799380000},"page":"333-336","source":"Crossref","is-referenced-by-count":1,"title":["Laparoscopic cholecystectomy under total intravenous anaesthesia in a patient with myotonic dystrophy type 1 (Steinert\u2019s disease) \u2013 a case report"],"prefix":"10.3897","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-6010","authenticated-orcid":true,"given":"Georgios","family":"Karras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Nikouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Kiamiloglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","published-online":{"date-parts":[[2022,4,30]]},"reference":[{"key":"59905_B1","unstructured":"1. Reilly CS. Clinical Anesthesia, 5th ed. Barash PG, Cullen BF, Stoelting RK (editors). Philadelphia, USA: Lippincott, Williams and Wilkins; 2006."},{"key":"59905_B2","doi-asserted-by":"crossref","unstructured":"2. Echeverry-Mar\u00edn PC, Bustamante-Vega \u00c1M. Anesthetic implications of muscular dystrophies. Rev Colomb de Anestesiol 2018; 46(3):228\u201339.","DOI":"10.1097\/CJ9.0000000000000059"},{"key":"59905_B3","doi-asserted-by":"crossref","unstructured":"3. Russell SH, Hirsch NP. Anaesthesia and myotonia. Br J Anaesth 1994; 72(2):210\u20136.","DOI":"10.1093\/bja\/72.2.210"},{"key":"59905_B4","doi-asserted-by":"crossref","unstructured":"4. Aldridge LM. Anaesthetic problems in myotonic dystrophy: a case report and review of the Aberdeen experience comprising 48 general anaesthetics in a further 16 patients. Br J Anaesth 1985; 57(11):1119\u201330.","DOI":"10.1093\/bja\/57.11.1119"},{"key":"59905_B5","doi-asserted-by":"crossref","unstructured":"5. Mathieu J, Allard P, Gobeil G, et al. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 1997; 49(6):1646\u201350.","DOI":"10.1212\/WNL.49.6.1646"},{"key":"59905_B6","doi-asserted-by":"crossref","unstructured":"6. Sinclair JL, Reed PW. Risk factors for perioperative adverse events in children with myotonic dystrophy. Pediatr Anesth 2009; 19(8):740\u20137.","DOI":"10.1111\/j.1460-9592.2009.03079.x"},{"key":"59905_B7","doi-asserted-by":"crossref","unstructured":"7. Azar I. The response of patients with neuromuscular disorders to muscle relaxants: a review. The Journal of the American Society of Anesthesiologists 1984; 61(2):173\u201387.","DOI":"10.1097\/00000542-198408000-00011"},{"key":"59905_B8","doi-asserted-by":"crossref","unstructured":"8. Bennun M, Goldstein B, Finkelstein Y, et al. Continuous propofol anaesthesia for patients with myotonic dystrophy. Br J Anaesth 2000; 85:407\u20139.","DOI":"10.1093\/bja\/85.3.407"},{"key":"59905_B9","doi-asserted-by":"crossref","unstructured":"9. Morimoto Y, Mii M, Hirata T, et al. Target-controlled infusion of propofol for a patient with myotonic dystrophy. J Anesth 2005; 19:336\u20138.","DOI":"10.1007\/s00540-005-0348-7"},{"key":"59905_B10","doi-asserted-by":"crossref","unstructured":"10. Mangla C, Bais K, Yarmush J. Myotonic dystrophy and anesthetic challenges: a case report and review. Case Rep Anesthesiol 2019; 2019:4282305.","DOI":"10.1155\/2019\/4282305"},{"key":"59905_B11","doi-asserted-by":"crossref","unstructured":"11. Speedy H. Exaggerated physiological responses to propofol in myotonic dystrophy. Br J Anaesth 1990; 64:110\u20132.","DOI":"10.1093\/bja\/64.1.110"},{"key":"59905_B12","doi-asserted-by":"crossref","unstructured":"12. Tzabar Y, Marshall R. Myotonic dystrophy and target-controlled propofol infusions. Br J Anaesth 1995; 74:108\u20139.","DOI":"10.1093\/bja\/74.1.108"},{"key":"59905_B13","doi-asserted-by":"crossref","unstructured":"13. Mudge BJ, Taylor PB, Vanderspek AF. Perioperative hazards in myotonic dystrophy. Anaesthesia 1980; 35(5):492\u20135.","DOI":"10.1111\/j.1365-2044.1980.tb03827.x"},{"key":"59905_B14","doi-asserted-by":"crossref","unstructured":"14. Lee HJ, Chon JY, Hwang SJ. Total intravenous anesthesia using bispectral index for transvaginal uterine myomectomy in a patient with myotonic dystrophy. Korean J Anesthesiol 2007; 53:238\u201341.","DOI":"10.4097\/kjae.2007.53.2.238"},{"key":"59905_B15","unstructured":"15. Catena V, Del Monte DD, Rubini A, et al. The role of intravenous anesthesia with propofol, cis-atracurium, and remifentanil. A case report. Minerva Anestesiol 2007; 73:475\u20139."},{"key":"59905_B16","unstructured":"16. Masamune T, Okawa I, Iwashita H, et al. Total intravenous anesthesia with propofol and remifentanil for a patient with myotonic dystrophy. Masui 2009; 58:620\u20132."},{"key":"59905_B17","unstructured":"17. Nakanishi T, Nishihama M, Hirai A, et al. Successful management of a patient with myotonic dystrophy under total intravenous anesthesia with propofol, remifentanil and rocuronium bromide, combined with epidural anesthesia. Masui 2010; 59:1419\u201322."},{"key":"59905_B18","doi-asserted-by":"crossref","unstructured":"18. Bisinotto FM, Fabri DC, Cal\u00e7ado MS, et al. Anesthesia for videolaparoscopic cholecystectomy in a patient with Steinert disease. Case report and review of the literature. Rev Bras Anestesiol 2010; 60:181\u201391.","DOI":"10.1016\/S0034-7094(10)70024-6"},{"key":"59905_B19","doi-asserted-by":"crossref","unstructured":"19. Kinney MA, Harrison BA. Propofol-induced myotonia in myotonic dystrophy. Anesth Analg 1996; 83:665\u20136.","DOI":"10.1213\/00000539-199609000-00067"},{"key":"59905_B20","doi-asserted-by":"crossref","unstructured":"20. Weinbroum AA. Role of anaesthetics and opioids in perioperative hyperalgesia: one step towards familiarisation. Eur J Anaesthesiol 2015; 32:230\u20131.","DOI":"10.1097\/EJA.0000000000000231"},{"key":"59905_B21","doi-asserted-by":"crossref","unstructured":"21. Teixeira J, Matias B, Ferreira I, et al. Sugammadex is changing the paradigm in neuromuscular blockade in patients with myotonic dystrophy. J Perioper Pract 2019; 29(10):337\u201340.","DOI":"10.1177\/1750458919838412"},{"key":"59905_B22","unstructured":"22. Mavridou P, Dimitriou V, Margaritis A, et al. Anesthesia for laparoscopic surgery in a patient with myotonic dystrophy (Steinert\u2019s disease): beneficial use of sugammadex, but incorrect use of pethidine: a case report. Acta Anaesthesiologica Belgica 2011; 62(2):101\u20134."},{"key":"59905_B23","doi-asserted-by":"crossref","unstructured":"23. Takhar AS, Thaper A, Byrne A, et al. Laparoscopic cholecystectomy in a patient with myotonic dystrophy. R Soc Med 2004; 97(6):284\u20135.","DOI":"10.1258\/jrsm.97.6.284"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/59905\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/59905\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=59905&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:56:37Z","timestamp":1652799397000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/59905\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,30]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4,30]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.64.e59905","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"type":"electronic","value":"1314-2143"},{"type":"print","value":"0204-8043"}],"subject":[],"published":{"date-parts":[[2022,4,30]]}}}